CAPN1 and breast carcinoma: For example, the expression of calpain-1 has been previously reported in HER2-positive breast cancer patients treated with trastuzumab following adjuvant chemotherapy and no association was found with any of the clinicopathological variables [8, 9].This observation is consistent with our current data but may differ in terms of the positivity of HER2.